ViewRay’s MRIdian Is Promising, But Losses Mount
The company’s MRIdian offers more accurate radiotherapy for cancer patients but they won’t have the field to themselves. Worries about the viability of the MRIdian are unfounded as a competitor […]
The company’s MRIdian offers more accurate radiotherapy for cancer patients but they won’t have the field to themselves. Worries about the viability of the MRIdian are unfounded as a competitor […]